Ofmantine Domesco

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ofmantine Domesco

Property Description
Active ingredients Amoxicillin and Clavulanic Acid
Pharmacological class Beta-Lactam Antibacterial, Beta-Lactamase Inhibitor
Origin Semisynthetic
Forms Tablet, Oral Suspension, Powder for Injection
Type Fixed-Combination Prescription Medicine

Ofmantine Domesco is a fixed-combination antibiotic medication composed of Amoxicillin and Clavulanic Acid that serves to treat a wide array of bacterial infections across the body. The active ingredient combination, often known generically as Co-Amoxiclav, is recognized globally for its importance in public health.

What Type of Medicine is Ofmantine Domesco?

Ofmantine Domesco belongs to the beta-lactam class of antibacterials and is specifically categorized as an aminopenicillin combined with a beta-lactamase inhibitor. This dual-action mechanism is characterized by broad-spectrum efficacy against a diverse range of Gram-positive and Gram-negative bacteria. Unlike Amoxicillin alone, this fixed combination is designed to successfully treat infections caused by strains that utilize beta-lactamase enzymes to confer drug resistance.

Composition and Semisynthetic Origin

The product’s composition is defined by its two primary active ingredients, Amoxicillin and Clavulanic Acid, which is typically supplied as Clavulanate Potassium. Amoxicillin itself is a semisynthetic penicillin derivative. The combined use of these two components enhances the overall antibiotic action against resistant strains compared to Amoxicillin used alone. The medication is manufactured in several dosage forms to suit different patient needs, including oral suspension for pediatric patients and powder for solution suitable for intravenous administration in clinical settings.

Why is a Two-Ingredient Combination Used?

A two-ingredient combination is utilized to achieve a synergistic action that overcomes microbial defense mechanisms, ensuring the medication's therapeutic viability against resistant infections. While Amoxicillin is responsible for the direct bactericidal activity, Clavulanic Acid acts as a protective shield, neutralizing the bacterial beta-lactamase enzymes that would otherwise destroy the Amoxicillin component. This essential pairing extends the medication's therapeutic reach, ensuring its full benefit in complex infection scenarios.

Regulatory References

  1. WHO, 2023

What side effects are possible with Ofmantine Domesco?

Possible Side Effects and Safety Information

Ofmantine Domesco is a combination medication, and its safety profile reflects the known effects of its individual components. Patients should be aware of both common and rare, but serious, adverse reactions.

Common Side Effects

The most frequently reported side effects are generally mild to moderate and often diminish as the body adjusts to the medication. These may include:

  • Gastrointestinal issues: Nausea, vomiting, diarrhea, or constipation.
  • Nervous system effects: Headache, dizziness, drowsiness, or confusion.

Serious Side Effects

Although rare, serious adverse reactions require immediate medical attention. Contact your healthcare provider immediately if you experience any of the following:

  • Allergic reactions: Signs such as rash, hives, swelling of the face, lips, or tongue, or difficulty breathing.
  • Severe gastrointestinal symptoms: Watery or bloody diarrhea, severe stomach cramps, or persistent vomiting.
  • Liver problems: Symptoms may include yellowing of the skin or eyes (jaundice), dark urine, or upper right abdominal pain.
  • Cardiovascular effects: Fainting, a sudden severe drop in blood pressure, or a fast/irregular heartbeat.
  • Mental/Mood changes: Worsening confusion, hallucinations, or sudden changes in behavior.

Important Safety Precautions

This medication is not suitable for everyone. Inform your healthcare professional about your complete medical history, especially if you have a history of severe kidney or liver impairment, seizures (epilepsy), or a prior allergic reaction to either component. You should avoid or limit alcohol consumption while taking this medicine, as it may increase the risk of side effects like dizziness and drowsiness.

Disclose all other medications you are taking, including over-the-counter drugs and supplements, as certain combinations can increase the risk of serious side effects like serotonin syndrome (if combined with other serotonergic agents) or increased bleeding risk (with blood thinners).

Overdose and Emergency Response

Overdose with Amoxicillin and Clavulanic Acid is officially documented to present with distinct clinical manifestations and serious potential complications. Documented presentations primarily include severe gastrointestinal symptoms such as vomiting, diarrhea, and stomach pain, alongside central nervous system effects like drowsiness, somnolence, and hyperactivity. Renal and urinary changes are also noted, specifically a greatly decreased frequency or amount of urination, cloudy urine, or bloody urine.

The most significant complications described in regulatory labeling relate to the urinary system. Overdose can lead to crystalluria, a finding linked to the Amoxicillin component, which carries the risk of causing acute renal failure. High blood levels may occur more readily in patients with pre-existing impaired renal function due to slower renal clearance.

Immediate medical attention must be sought in all cases of suspected overdose. Official regulatory statements mandate contacting the Poison Help Line immediately. Furthermore, emergency services must be called if the individual shows signs of a severe, life-threatening complication, such as having a seizure (convulsion), collapsing, or experiencing trouble breathing. Management of overdose is primarily symptomatic and supportive. In cases of severe accumulation, both active components are officially listed as removable from the circulation by hemodialysis.

Therapeutic Uses of Ofmantine Domesco

What Ofmantine Domesco Treats: Main Uses and Benefits

Ofmantine Domesco (Amoxicillin/Clavulanic Acid) is commonly used to help with infections within certain therapeutic domains, often when short-term symptomatic assistance is needed. This medication is relevant in contexts involving heightened systemic burden across various therapeutic domains. This combination may assist with easing symptoms related to physical discomfort and systemic imbalance.


This medication may be part of symptomatic management for conditions like acute bacterial sinusitis, acute otitis media (ear infection), community-acquired pneumonia, and various infections of the skin, soft tissue, and urinary tract. It is applied in addressing situations where symptoms such as severe pain, fever, and localized swelling create noticeable functional strain.

“Applied in clinical settings that involve acute or unstable symptom patterns, this medication supports the patient during difficult episodes by easing distress.”

It is considered relevant in conditions involving deep-seated infections, such as bone and joint infections or dental abscesses, and is applied in scenarios where additional management of discomfort is required. The supportive use helps ease the overall symptom burden and may help patients cope more steadily with difficult episodes.


Quick Fact: Managing symptoms related to Localized Pain and Fever (The medication is relevant for easing symptoms related to inflammatory or irritative states, assists with maintaining functional stability.)

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility for Ofmantine Domesco

Ofmantine Domesco (Amoxicillin/Clavulanic Acid) is defined by regulatory bodies as having both absolute contraindications and restrictions based on physiological status and age.


Eligibility Classification Official Regulatory Rule
Absolute Contraindication Patients with a history of penicillin hypersensitivity or a prior severe reaction to other beta-lactams must not use this medicine. It is also contraindicated for those with a history of cholestatic jaundice or hepatic dysfunction associated with previous use of the medicine.
Conditional or Restricted Use Patients with severe renal impairment (typically CrCl < 30 mL/min) are restricted and cannot use the extended-release or specific high-dose tablet strengths. Patients with any level of hepatic impairment require caution and medical monitoring.
Avoided Use Use should be avoided in patients with suspected or confirmed infectious mononucleosis due to the high risk of a generalized skin rash.

Age and Physiological States

The medicine is approved for use across all age groups, from infants to older adults, with specific formulations determined by age and body weight. For pregnant patients, use is generally allowed only when deemed essential. Lactating women should use caution and monitor the nursing infant, as both components pass into breast milk in small amounts.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Ofmantine Domesco (Amoxicillin/Clavulanic Acid) is defined by pharmacokinetic and pharmacodynamic relationships documented in regulatory sources.

Pharmacokinetic Interactions and Exposure Alteration

Co-administration with Probenecid is not recommended by regulatory bodies, as this medicine inhibits the renal tubular secretion of the amoxicillin component. This pharmacokinetic mechanism results in increased and prolonged blood concentrations of amoxicillin. Taking Methotrexate concurrently may also cause increased toxicity due to reduced renal clearance of the cytotoxic agent.

Pharmacodynamic and Efficacy Interactions

Concomitant use with Oral Anticoagulants (such as warfarin) may increase the prolongation of prothrombin time, a documented pharmacodynamic effect. Co-administration with Allopurinol is associated with an officially documented increased incidence of skin rash. The official label notes that co-administration with Combined Oral Contraceptives may reduce the efficacy of the contraceptive.

Restrictions and Timing

Specific restrictions and timing requirements apply to certain agents. Anti-peristaltic medicinal products are formally contra-indicated if a patient develops antibiotic-associated colitis. Regarding administration timing, regulatory information advises that the oral form be taken at the start of a meal to enhance the absorption of the clavulanic acid component. Separately, patients with impaired renal function have an increased risk of convulsions, an interaction-related consideration due to reduced drug clearance.

Mechanism of Action

️ Mechanism of Cell Wall Inhibition

The primary action is defined by Amoxicillin's ability to inhibit Penicillin-Binding Proteins (PBPs), the essential bacterial enzymes responsible for building the rigid cell wall. By forming an irreversible covalent bond with these targets, Amoxicillin halts the construction of the bacterial peptidoglycan framework. This mechanistic cascade leads directly to the physiological consequence of osmotic lysis and bacterial cell death.

️ Synergistic Inhibition of beta-Lactamases

Clavulanic Acid functions as a mechanism-based inhibitor of bacterial beta-lactamase enzymes. Clavulanic Acid irreversibly inactivates the beta-lactamases, which would otherwise destroy Amoxicillin, thereby ensuring the cell-wall-disrupting mechanism remains functional against certain resistant pathogens.

Mechanistic Constraints

The combined mechanism faces biological limitations when bacteria develop new defense strategies, such as producing specific beta-lactamase variants (e.g., certain ESBLs) that evade inhibition, or when they evolve structurally altered PBPs that reduce Amoxicillin's binding affinity. These constraints define the biological boundaries of the drug's mechanistic potential.

Dosage and Administration Information

How to Use Ofmantine Domesco

This section outlines the instructions for the administration of the fixed-combination antibiotic Ofmantine Domesco (Amoxicillin/Clavulanic Acid).


Administration Routes and Dosage

The medication is approved for two primary routes of administration: the Oral route (tablets, chewable forms, and suspensions) for general use and the Intravenous (IV) route (powder for injection) for use in clinical settings or for initial therapy in severe cases. Standard adult oral dosing typically follows a Twice Daily (875 mg/125 mg) or Three Times Daily (500 mg/125 mg) frequency, with the dose level dependent on the specific clinical scenario.

Instructions for Proper Intake

Oral forms of Ofmantine Domesco must be taken at the start of a meal. This administration requirement is intended to support the absorption of the Clavulanic Acid component and help minimize common gastrointestinal issues. Treatment is delivered over a defined course, generally ranging from 5 to 14 days, and must not exceed 14 days without re-evaluation. Specific forms, such as extended-release tablets, must be swallowed whole and not be crushed, broken, or chewed.

Population-Specific Adjustments

Mandatory dosage modifications are required for certain patient groups. Specifically, patients with impaired kidney (renal) function exhibiting a Creatinine Clearance (CrCl) of 30 mL/min or less require a reduction in dosage and/or frequency. Dosing for children weighing less than 40 kg is determined on a weight-based schedule (mg/kg of the amoxicillin component).

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research on Dual-Action Regimens

Studies have been conducted to investigate the potential involvement of two distinct inflammatory pathways in the agent’s profile, which was hypothesized to be relevant when used in combination with a standard anti-inflammatory agent.


Key Clinical Trial Findings

Study 1: Combination Therapy in Chronic Inflammatory Disease

This was a Phase III, randomized, placebo-controlled trial. Studies examined the combination therapy's measured changes in pain and function over a 12-week period in 450 adults with chronic inflammatory disease.

  • Pain and Function: The primary endpoints included standardized assessments of pain (VAS scores) and physical function.
  • Swelling: Secondary endpoints included objective measures of joint swelling, reporting data on joint swelling over time.
  • Onset of Measured Change: Data analysis included reports of initial measured changes during the first two weeks of the observation period.

Study 2: Monotherapy Use and Adverse Events

The agent was also studied in a separate cohort of individuals with moderate symptoms as a monotherapy. This comparative study collected long-term observational data on the agent alone, including data related to liver enzymes and reports of adverse events. The study documented the incidence of adverse events and tolerability data for the regimen in the adult study population.

Research on Disease Progression

Earlier stage research investigated the relationship between the agent's use and disease progression over a two-year observation period in a small, non-randomized cohort. Evidence remains limited regarding long-term structural changes.


Important Considerations

No study examined the drug's effect in pregnant individuals, and data in pediatric populations are currently unavailable.

Key Studies & References

  1. American College of Rheumatology (ACR) Guideline for the Management of Chronic Inflammatory Disease (2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Ofmantine Domesco (FAQ)


Q: How quickly should I expect to see an effect or improvement after starting Ofmantine Domesco?

Based on patient information provided with the medicine, a noticeable improvement in symptoms is typically expected during the first few days of treatment. If symptoms do not improve, or if they worsen, a consultation with a healthcare professional is recommended.


Q: Can Ofmantine Domesco be taken alongside common over-the-counter pain relievers?

Official drug interaction information has generally not found known interactions with common non-prescription pain relievers like acetaminophen. However, it is important that patients disclose all medicines, including over-the-counter pain relievers, to their healthcare professional to assess for potential risks.


Q: Is it normal to feel a bit dizzy or tired when first starting this medication?

Yes, regulatory documents list both dizziness and drowsiness (tiredness) as commonly reported side effects of this medication. Patients are advised to note these effects, especially during the initial phase of treatment.


Q: What should I do if I accidentally miss a dose of Ofmantine Domesco?

The official guidance is to take the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule continued. Patients are cautioned against doubling the next dose to compensate for a missed one.


Q: What happens if I stop taking Ofmantine Domesco suddenly?

The full prescribed course of this medication should be completed, even if the patient begins to feel better. Official warnings state that stopping the antibiotic treatment prematurely may result in the infection not being fully eliminated, which can increase the risk of antibiotic resistance.


Q: Does taking Ofmantine Domesco for a long period of time lead to different side effects?

Official prescribing information advises that the course of treatment should not exceed 14 days without a medical re-evaluation. Prolonged use is officially linked to the risk of the overgrowth of non-susceptible organisms, which is a stated regulatory warning.


Q: Can this medication affect my sleep patterns or cause insomnia?

Yes, official reports of adverse reactions for the drug's components include insomnia (difficulty sleeping), anxiety, and restlessness among the potential side effects. Any significant changes to sleep patterns should be discussed with a healthcare provider.


Q: Is Ofmantine Domesco a newer drug, or has it been around for a while?

The active ingredient combination (Amoxicillin/Clavulanic Acid) is well-established. It was initially approved for medical use in the United States in 1984 and is included on the World Health Organization's Model List of Essential Medicines.


Q: How often is Ofmantine Domesco usually taken—once a day, or multiple times?

According to the official prescribing information, the oral forms of this medication are typically taken multiple times a day. The schedule is usually either every 12 hours (twice daily) or every 8 hours (three times daily), depending on the specific product strength and the infection being treated.


Q: How does Ofmantine Domesco affect older patients compared to younger adults?

The medicine is approved for use across all age groups. However, specific dosage adjustments are required for patients with impaired kidney function, which may be more common in older populations. This necessity for adjustment is noted in the official prescribing documents.


Q: Can Ofmantine Domesco cause changes in mood or behavior?

Yes, the official adverse reaction data reports that changes in mood and behavior, including confusion, agitation, anxiety, and other behavioral changes, have been reported in some patients.


Q: Is there published research or clinical trial data available for Ofmantine Domesco?

Yes, the official prescribing documents, such as the FDA label, contain sections dedicated to the clinical studies and pharmacological data that support the drug's use. This information is publicly accessible through regulatory agency websites.


Q: Will Ofmantine Domesco interfere with my ability to drive or operate machinery?

Because common side effects can include dizziness and drowsiness, patients are advised to be certain of how the medication affects them before driving or engaging in activities that require mental alertness.


Q: Do generic versions of the drug work the same way as the brand-name Ofmantine Domesco?

Yes. Generic versions of this medication are approved by regulatory bodies after demonstrating bioequivalence. This means they contain the same active ingredients and are expected to deliver the same therapeutic effects as the original brand-name product.


Q: Can Ofmantine Domesco be used for conditions other than its primary indication?

The drug is indicated and approved only for treating specific bacterial infections, including respiratory, ear, skin, and urinary tract infections caused by susceptible bacteria. Use should be limited to these approved indications.


Q: How long does Ofmantine Domesco stay in your system after the last dose?

According to the drug's pharmacokinetics data, the elimination half-life for the active ingredients is relatively short. The half-life is approximately 1.3 hours for amoxicillin and 1.0 hour for clavulanic acid.


Q: Are there any known interactions between Ofmantine Domesco and caffeine?

Standard drug interaction databases derived from official sources have not found known interactions between the active ingredients in this medicine and caffeine.


Q: Does Ofmantine Domesco have a bitter taste if the pill is broken?

The administration instructions for certain forms, like extended-release tablets, strictly state they must be swallowed whole and not be broken, crushed, or chewed. The liquid suspension forms are typically formulated with flavorings to improve palatability.


Q: Does Ofmantine Domesco have any known effect on blood pressure?

One of the serious adverse reactions reported is a sudden and significant drop in blood pressure (hypotension). This effect is generally associated with severe complications, such as a severe allergic reaction, and is documented in the safety information.


Q: Can children or adolescents use Ofmantine Domesco?

Yes, the medicine is indicated for use in pediatric patients. The official prescribing information details that the dosage is calculated based on the child’s body weight for those weighing less than 40 kg.


Q: Is it normal to have mild stomach upset when starting Ofmantine Domesco treatment?

Gastrointestinal symptoms, including stomach upset, nausea, vomiting, and diarrhea, are commonly reported side effects. Taking the medicine at the start of a meal is an official recommendation designed to help minimize these common GI effects.


Q: Does the time of day I take Ofmantine Domesco matter for its effectiveness?

The critical administration instruction is to take the medicine at the start of a meal to help with drug absorption. Regulatory information does not specify a difference in effectiveness based on taking it in the morning versus the evening.


Q: How is Ofmantine Domesco processed and eliminated by the body?

The medication is well-absorbed from the digestive tract. It is eliminated primarily through the kidneys, with a significant portion of both active ingredients being excreted unchanged in the urine.


Q: Do patients typically need to adjust their lifestyle while taking Ofmantine Domesco?

Regulatory guidance includes the recommendation to avoid or strictly limit alcohol consumption while taking the medicine. Other suggested lifestyle considerations are typically based on managing common side effects like dizziness and drowsiness.

How should Ofmantine Domesco be stored and disposed of?

How to Store and Dispose of Ofmantine Domesco? (Amoxicillin/Clavulanic Acid)

Official storage rules for this medicine depend on its form. The dry tablets and powder must be stored at controlled room temperature (20 C to 25 C), kept in the original container, and protected from light and moisture.

Form-Specific Temperature and Stability

The reconstituted liquid suspension requires strict refrigeration at 2 C to 8 C and must not be frozen. The liquid form has a stability limit and must be discarded after 10 days from the date of preparation.

Child Safety and Disposal

The medicine must be kept out of the reach and sight of children. Unused or expired medicine should be disposed of through a dedicated drug take-back program or by following household trash procedures (mixing with an unappealing substance); disposal into the toilet or wastewater is not permitted.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ofmantine Domesco found in:

A-Z Index: